BACTERIOPHAGES AS ANTIBIOTICS ALTERNATIVES TO COMBAT MULTIDRUG RESISTANT PATHOGENS: A REVIEW ARTICLE

Abstract

Antibodies, probiotics, and antimicrobial peptides are currently undergoing clinical studies as potential options to treat infections as bacteria become more resistant to traditional antibiotics and as more medications lose their efficacy against drug-resistant bacteria. In various regions of the world, bacteriophages have also been employed as a form of therapy. The advantage of these approaches is that the disease-causing bacteria are the only ones that are treated, leaving the beneficial commensal microbial communities of the host intact. This antimicrobial does not typically have an impact on commensal bacteria in addition to its pathogenic targets, as do the majority of antibiotics. The phage exhibits a great bactericidal effect while altering the normal flora very little. The medical benefits of phages for antibioticresistant and sensitive robotic microorganisms are comparable These unique disease-treating techniques must be further developed in order to improve their availability, effectiveness, and dependability as antibiotic substitutes